
201 - 500 employees
Founded 1997
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $525.3k Post-IPO Equity on 2012-04
Biotechnology • Pharmaceuticals • Science
Corcept Therapeutics is a biopharmaceutical company focused on unlocking the potential of cortisol modulation to revolutionize the treatment of serious diseases. The company is dedicated to understanding and modulating cortisol activity at the glucocorticoid receptor to develop novel treatments for severe disorders. With more than 30 ongoing studies, Corcept is building a scientific foundation to deliver new approaches in fields such as endocrinology, oncology, metabolism, and neurology. The company aims to bring innovative therapies to patients by exploring new possibilities in cortisol modulation science.
🕒 June 24
Medical Science Liaison at Corcept Therapeutics focuses on endocrinology and engages with healthcare professionals about Cushing’s syndrome. Requires strong scientific expertise and established relationships in the medical community.
🏛️ District of Columbia – Remote
💵 $172.3k - $253.3k / year
💰 $525.3k Post-IPO Equity on 2012-04
⏰ Full Time
🟠 Senior
🔴 Lead
🦅 H1B Visa Sponsor
🕒 June 10
Senior Manager developing thought leader programming strategies at Corcept Therapeutics. Driving peer-to-peer education and translating insights into educational and commercial strategies.
🇺🇸 United States – Remote
💵 $155k - $205.1k / year
💰 $525.3k Post-IPO Equity on 2012-04
⏰ Full Time
🟠 Senior
👔 Manager
🦅 H1B Visa Sponsor
🕒 June 8
Associate Director driving digital and omnichannel marketing strategies for Corcept's oncology product Lifyorli. Collaborating across teams to enhance customer engagement in the healthcare sector.
🏄 California – Remote
💵 $172.2k - $227.9k / year
💰 $525.3k Post-IPO Equity on 2012-04
⏰ Full Time
🟠 Senior
🎡 Marketing
🦅 H1B Visa Sponsor